Idiopathic Recurrent Angioedema

Immunology and Allergy Clinics of North America

Volumn 26, Issue 4, 2006, Pages 739-751

  Frigas, Evangelo ^a   Park, Miguel ^a  

^a Mayo Clinic College of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIHISTAMINIC AGENT; CAPTOPRIL; CETIRIZINE; COLCHICINE; CYCLOSPORIN; DAPSONE; DESLORATADINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPHENHYDRAMINE; DOXEPIN; ESTROGEN; FEXOFENADINE; HYDROXYZINE; INDOMETACIN; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LORATADINE; LOSARTAN; METHOTREXATE; NARCOTIC AGENT; NIFEDIPINE; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL CONTRACEPTIVE AGENT; POLYMYXIN; RECOMBINANT ALPHA INTERFERON; SALAZOSULFAPYRIDINE; TUBOCURARINE CHLORIDE; UNINDEXED DRUG; WARFARIN;

ABDOMINAL PAIN; ANGIONEUROTIC EDEMA; CLINICAL FEATURE; CLINICAL TRIAL; DIFFERENTIAL DIAGNOSIS; DOSE RESPONSE; ENDOSCOPY; EOSINOPHIL; EXTRAVASATION; FAMILY HISTORY; FOLLOW UP; HUMAN; IDIOPATHIC DISEASE; IMMUNOLOGY; IMMUNOPATHOGENESIS; MAST CELL; PHYSICAL EXAMINATION; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PRURITUS; RADIODIAGNOSIS; REVIEW; SKIN CARE; SKIN SWELLING; SYSTEMIC THERAPY; UNSPECIFIED SIDE EFFECT; URTICARIA;

ANGIONEUROTIC EDEMA; DIAGNOSIS, DIFFERENTIAL; HUMANS; RECURRENCE;

EID: 33750527791     PISSN: 08898561     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.iac.2006.09.004     Document Type: Review

References (48)

1. Cugno M., Nussberger J., Cicardi M., et al. Bradykinin and the pathophysiology of angioedema. Int Immunopharmacol 3 3 (2003) 311-317
2. Kaplan A.P., and Greaves M.W. Angioedema. J Am Acad Dermatol 53 3 (2005) 373-388
3. Frigas E., and Nzeako U.C. Angioedema. Pathogenesis, differential diagnosis, and treatment. Clin Rev Allergy Immunol 23 2 (2002) 217-231
4. Mathews K.P. Urticaria and angioedema. J Allergy Clin Immunol 72 1 (1983) 1-14
5. Beltrani V.S. Angioedema: some "new" thoughts regarding idiopathic angioedema. In: Greaves M.W., and Kaplan A.P. (Eds). Urticaria and angioedema (2004), Marcel Dekker, New York 421-439
6. Champion R.H., Greaves M.W., Black A.K., et al. The urticarias (1985), Churchill Livingstone, Edinburgh
7. Champion R.H. Urticaria: then and now. Br J Dermatol 119 4 (1988) 427-436
8. Krause K.H., Rentrop U., and Mehregan U. Cerebral manifestations in angioneurotic edema. J Neurol Sci 42 3 (1979) 429-435 [in German]
9. Pellacani A., Brunner H.R., and Nussberger J. Plasma kinins increase after angiotensin-converting enzyme inhibition in human subjects. Clin Sci (Lond) 87 5 (1994) 567-574
10. Nussberger J., Cugno M., and Cicardi M. Bradykinin-mediated angioedema. N Engl J Med 347 8 (2002) 621-622
11. Casale T.B., Sampson H.A., Hanifin J., et al. Guide to physical urticarias. J Allergy Clin Immunol 82 5 Pt 1 (1988) 758-763
12. Gorevic P.D. Cryopathies: cryoglobulins and cryofibrinogenemia. In: Frank M.M., Austen K.F., Claman H.N., et al. (Eds). Samter's immunologic diseases. 5th edition vol 2 (1995), Little, Brown and Company, Boston 951-974
13. Nzeako U.C., Frigas E., and Tremaine W.J. Hereditary angioedema: a broad review for clinicians. Arch Intern Med 161 20 (2001) 2417-2429
14. Leznoff A., Josse R.G., Denburg J., et al. Association of chronic urticaria and angioedema with thyroid autoimmunity. Arch Dermatol 119 8 (1983) 636-640
15. Leznoff A., and Sussman G.L. Syndrome of idiopathic chronic urticaria and angioedema with thyroid autoimmunity: a study of 90 patients. J Allergy Clin Immunol 84 1 (1989) 66-71
16. Gruber B.L., Baeza M.L., Marchese M.J., et al. Prevalence and functional role of anti-IgE autoantibodies in urticarial syndromes. J Invest Dermatol 90 2 (1988) 213-217
17. Grattan C.E., Hamon C.G., Cowan M.A., et al. Preliminary identification of a low molecular weight serological mediator in chronic idiopathic urticaria. Br J Dermatol 119 2 (1988) 179-183
18. Hide M., Francis D.M., Grattan C.E., et al. Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria. N Engl J Med 328 22 (1993) 1599-1604
19. Fiebiger E., Maurer D., Holub H., et al. Serum IgG autoantibodies directed against the α chain of FcεRI: a selective marker and pathogenetic factor for a distinct subset of chronic urticaria patients?. J Clin Invest 96 6 (1995) 2606-2612
20. Fiebiger E., Hammerschmid F., Stingl G., et al. Anti-FcεRIα autoantibodies in autoimmune-mediated disorders: identification of a structure-function relationship. J Clin Invest 101 1 (1998) 243-251
21. Niimi N., Francis D.M., Kermani F., et al. Dermal mast cell activation by autoantibodies against the high affinity IgE receptor in chronic urticaria. J Invest Dermatol 106 5 (1996) 1001-1006
22. Ferrer M., Kinet J.P., and Kaplan A.P. Comparative studies of functional and binding assays for IgG anti-FcεRIα (α-subunit) in chronic urticaria. J Allergy Clin Immunol 101 5 (1998) 672-676 Erratum in. J Allergy Clin Immunol 1998;102(1):156
23. Sabroe R.A., Fiebiger E., Francis D.M., et al. Classification of anti-FcεRI and anti-IgE autoantibodies in chronic idiopathic urticaria and correlation with disease severity. J Allergy Clin Immunol 110 3 (2002) 492-499
24. Ferrer M., Nakazawa K., and Kaplan A.P. Complement dependence of histamine release in chronic urticaria. J Allergy Clin Immunol 104 1 (1999) 169-172 Erratum in. J Allergy Clin Immunol 2000;105(2):392
25. Kikuchi Y., and Kaplan A.P. A role for C5a in augmenting IgG-dependent histamine release from basophils in chronic urticaria. J Allergy Clin Immunol 109 1 (2002) 114-118
26. Horn M.P., Pachlopnik J.M., Vogel M., et al. Conditional autoimmunity mediated by human natural anti-FcεRIα autoantibodies?. FASEB J 15 12 (2001) 2268-2274
27. Pachlopnik J.M., Horn M.P., Fux M., et al. Natural anti-FcεRIα autoantibodies may interfere with diagnostic tests for autoimmune urticaria. J Autoimmun 22 1 (2004) 43-51
28. Confino-Cohen R., Aharoni D., Goldberg A., et al. Evidence for aberrant regulation of the p21Ras pathway in PBMCs of patients with chronic idiopathic urticaria. J Allergy Clin Immunol 109 2 (2002) 349-356
29. Grattan C.E., Francis D.M., Slater N.G., et al. Plasmapheresis for severe, unremitting, chronic urticaria. Lancet 339 8801 (1992) 1078-1080
30. O'Donnell B.F., Barr R.M., Black A.K., et al. Intravenous immunoglobulin in autoimmune chronic urticaria. Br J Dermatol 138 1 (1998) 101-106
31. Grattan C.E., O'Donnell B.F., Francis D.M., et al. Randomized double-blind study of cyclosporin in chronic 'idiopathic' urticaria. Br J Dermatol 143 2 (2000) 365-372
32. Gach J.E., Sabroe R.A., Greaves M.W., et al. Methotrexate-responsive chronic idiopathic urticaria: a report of two cases. Br J Dermatol 145 2 (2001) 340-343
33. Kozel M.M., Mekkes J.R., Bossuyt P.M., et al. The effectiveness of a history-based diagnostic approach in chronic urticaria and angioedema. Arch Dermatol 134 12 (1998) 1575-1580
34. Agostoni A., Aygoren-Pursun E., Binkley K.E., et al. Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond. J Allergy Clin Immunol 114 3 Suppl (2004) S51-S131
35. Bork K., Fischer B., and Dewald G. Recurrent episodes of skin angioedema and severe attacks of abdominal pain induced by oral contraceptives or hormone replacement therapy. Am J Med 114 4 (2003) 294-298
36. Greaves M.W. Chronic urticaria as new autoimmune disease?. In: Hertl M. (Ed). Autoimmune diseases of the skin: pathogenesis, diagnosis, management (2001), Springer, Wien 283-302
37. Rumbyrt J.S., and Schocket A.L. Chronic urticaria and thyroid disease. Immunol Allergy Clin North Am 24 2 (2004) 215-223
38. Winkelmann R.K., and Frigas E. Eosinophilic panniculitis: a clinicopathologic study. J Cutan Pathol 13 1 (1986) 1-12
39. Gleich G.J., Schroeter A.L., Marcoux J.P., et al. Episodic angioedema associated with eosinophilia. N Engl J Med 310 25 (1984) 1621-1626
40. Bressler R.B., Sowell K., and Huston D.P. Therapy of chronic idiopathic urticaria with nifedipine: demonstration of beneficial effect in a double-blinded, placebo-controlled, crossover trial. J Allergy Clin Immunol 83 4 (1989) 756-763
41. Weiner M.J. Methotrexate in corticosteroid-resistant urticaria. Ann Intern Med 110 10 (1989) 848
42. Wong E., Eftekhari N., Greaves M.W., et al. Beneficial effects of danazol on symptoms and laboratory changes in cholinergic urticaria. Br J Dermatol 116 4 (1987) 553-556
43. Parsad D., Pandhi R., and Juneja A. Stanozolol in chronic urticaria: a double blind, placebo controlled trial. J Dermatol 28 6 (2001) 299-302
44. Parslew R., Pryce D., Ashworth J., et al. Warfarin treatment of chronic idiopathic urticaria and angio-oedema. Clin Exp Allergy 30 8 (2000) 1161-1165
45. Wiles J.C., Hansen R.C., and Lynch P.J. Urticarial vasculitis treated with colchicine. Arch Dermatol 121 6 (1985) 802-805
46. Nurnberg W., Grabbe J., and Czarnetzki B.M. Urticarial vasculitis syndrome effectively treated with dapsone and pentoxifylline. Acta Derm Venereol 75 1 (1995) 54-56
47. Jaffer A.M. Sulfasalazine in the treatment of corticosteroid-dependent chronic idiopathic urticaria. J Allergy Clin Immunol 88 6 (1991) 964-965
48. Engler R.J., Squire E., and Benson P. Chronic sulfasalazine therapy in the treatment of delayed pressure urticaria and angioedema. Ann Allergy Asthma Immunol 74 2 (1995) 155-159